Sepsis Global Market Report 2025

Sepsis is a life-threatening condition resulting from the body's extreme response to an infection. It occurs when the immune system releases chemicals into the bloodstream to combat the infection, but these chemicals trigger widespread inflammation, leading to tissue damage, organ failure, and potentially death.

The primary aspects of sepsis management include diagnosis and therapeutics. Diagnosis focuses on detecting sepsis through various tests and procedures that identify infections and assess their severity. The condition can be caused by pathogens such as bacteria, viruses, and fungi. Sepsis-related applications include severe sepsis and septic shock, with utilization in hospitals, pathology labs, and reference laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The sepsis market research report is one of a series of new reports from The Business Research Company that provides sepsis market statistics, including the sepsis industry's global market size, regional shares, competitors with a sepsis market share, detailed sepsis market segments, market trends and opportunities, and any further data you may need to thrive in the sepsis industry. This sepsis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sepsis market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increase in sepsis incidence due to aging populations, rise in prevalence of chronic diseases, growth in awareness of sepsis among healthcare providers, escalating healthcare expenditure, and implementation of government initiatives for early detection and management.

The sepsis market size is expected to see strong growth in the next few years. It will grow to $1.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing adoption of artificial intelligence in critical care, rising prevalence of multidrug-resistant infections, growing awareness campaigns about sepsis, expanding healthcare infrastructure in emerging economies, and increasing investments in biotechnology and pharmaceutical research. Major trends in the forecast period include development of rapid point-of-care diagnostics, adoption of AI-driven predictive analytics, personalized antibiotic stewardship programs, advancements in blood culture techniques, innovative biomarker identification, and development of novel therapies targeting immune modulation.

The forecast of 8.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of rapid sepsis biomarker tests and broad-spectrum IV antibiotics sourced from France and India, thereby delaying critical treatment initiation and elevating Intensive Care Unit expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of infectious diseases is expected to drive the expansion of the sepsis market in the coming years. Infectious diseases, caused by bacteria, viruses, fungi, or parasites, can spread through direct contact, contaminated sources, or insect vectors. Common examples include tuberculosis, influenza, ringworm, and malaria. Several factors contribute to the increasing incidence of infectious diseases, including globalization, environmental changes, drug-resistant pathogens, and gaps in healthcare systems. Sepsis, a severe complication of infections, results from the body's extreme response, leading to widespread inflammation and potential organ failure. For example, in November 2024, the Centers for Disease Control and Prevention reported that the United States recorded 9,633 cases of tuberculosis (TB) in 2023, marking a 15.6% increase from the 8,332 cases reported in 2022. Consequently, the rising burden of infectious diseases is fueling the growth of the sepsis market.

Companies in the sepsis market are leveraging advanced technology, such as artificial intelligence (AI)-powered platforms, to improve early diagnosis, enhance treatment precision, and predict patient outcomes. These innovations aim to reduce mortality rates and enhance healthcare efficiency in managing sepsis. For instance, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare company, launched OpenDX, an AI-powered diagnostic platform integrating wearable biosensors to detect early signs of sepsis. This technology aids in sepsis diagnosis and has the potential for application in other medical conditions, highlighting the increasing role of AI in diagnostics. Predicate's chest sensor enables healthcare professionals to identify early indicators of sepsis, a condition that is often challenging to diagnose.

In April 2024, Prenosis Inc., a US-based biotechnology research company, partnered with Roche Holding AG to advance sepsis diagnosis and management through AI-driven technology. As part of the partnership, Roche will distribute Prenosis' Sepsis ImmunoScore, an AI-based medical software designed to assist healthcare providers in rapidly diagnosing sepsis and predicting adverse outcomes. This collaboration enhances clinical sepsis management by integrating AI technology into healthcare settings. Roche Holding AG is a Switzerland-based pharmaceutical company specializing in oncology, immunology, infectious diseases, and other medical fields.

Major players in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott laboratories, Novartis AG, Siemens AG, Asahi Kasei Corporation, Becton, Dickinson and Company, bioMerieux SA, QuidelOrtho Corporation, Diasorin S.p.A., Innoviva Inc., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.

North America was the largest region in the sepsis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sepsis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sepsis market includes revenues earned by entities by providing services such as blood culture testing, molecular diagnostics, biomarker testing, intravenous (IV) fluid management, organ support services, and tele-ICU services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sepsis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sepsis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sepsis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sepsis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diagnosis; Therapeutics
• 2) By Pathogen: Bacterial; Viral; Fungal
• 3) By Application: Severe Sepsis; Septic Shock
• 4) By End User: Hospitals; Pathology; Reference Laboratories
• Subsegments:
• 1) By Diagnosis: Blood Tests; Imaging Techniques; Microbiological Culture Tests; Biomarker Tests; Other Diagnostic Methods
• 2) By Therapeutics: Antibiotics; Antifungal Agents; Vasopressors; Immunoglobulins; Corticosteroids; Other Therapeutic Options
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck KGaA; Bayer AG; Thermo Fisher Scientific Inc.; Abbott laboratories; Novartis AG; Siemens AG; Asahi Kasei Corporation; Becton, Dickinson and Company; bioMerieux SA; QuidelOrtho Corporation; Diasorin S.p.A.; Innoviva Inc.; Seegene Inc.; EKF Diagnostics; Boditech Med Inc.; Cytovale Inc.; Alifax S.r.l.; Hansa Biopharma; Amomed Pharma GmbH; Inotrem S.A.; Abionic SA; Biosystems Inc.; Immunexpress Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.